RE: RNS - 1/2 year report out - 57% increase in revenue13 Aug 2024 16:26
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) said its Phase 1 Clinical Trial for IB003, its gallium maltolate children's brain cancer treatment, is in the final stages. , Proactive describing as a Childrenβs brain cancer treatmdnt